An NCI-designated Comprehensive Cancer Center

Cutaneous Lymphoma

Cutaneous lymphoma (also called lymphoma of the skin) is a rare type of non-Hodgkin lymphoma that affects the skin. According to the American Cancer Society, there are approximately 72,580 cases of NHL diagnosed each year, only 5 percent of which are skin lymphomas.

City of Hope has one of the nation's most distinguished skin lymphoma programs. We pride ourselves on having one of the few multidisciplinary clinics in the country that treats the full spectrum of disease, whether you are newly-diagnosed, have cancer that has returned or have failed other therapies. We offer all traditional — and many novel — therapies to control, and when possible, cure these diseases, including skin-directed and infusional therapies, immunotherapies, biologic therapies, clinical trials and stem cell transplants — all managed by the same team of professionals, who are part of your care team at all levels of your medical care.

Request a consultation

If you have been diagnosed with acute myeloid leukemia or are looking for a second opinion consultation about your treatment, you may request an appointment online or contact us at 800-826-4673 (HOPE). Please visit Making Your First Appointment for more information. 

Our Expertise

Multidisciplinary care

City of Hope is one of only a few dozen centers in the country that treat cutaneous lymphomas using a comprehensive approach — by a multidisciplinary team whose sole focus is treating this type of cancer.

Your care includes regular interaction and input from a team of experts that includes dermatologists, medical oncologists and radiation oncologists — along with dermatopathologists, nurses, social workers and supportive care — with all interaction occurring in the same clinic space.

This team brings together deep experience and diverse perspectives, shaped by seeing and treating skin lymphomas every day, to arrive at the ideal treatment for every patient.

Strengths of our cutaneous lymphoma program include:

  • An approach that places the patient in the center — putting your needs and care at the center of all interactions with our multidisciplinary team.
  • Access to the latest treatments and research designed to better understand the disease and define new treatments.
  • Pathologic diagnostics to characterize skin lymphoma subtypes, using state of the art genetic and molecular testing. This includes molecularly profiling tumor types to reveal specific abnormalities unique to each patient, allowing for tailored therapeutic approaches and personalized medicine.
  • Promising new therapies as part of our clinical trials program — including an upcoming CAR T cell therapy trial — that provide additional treatment options.
  • A pioneering stem cell and bone marrow transplant program that is one of the largest in the United States. Our transplant outcomes are consistently highly-ranked by the Center for International Blood and Marrow Transplant Research. And innovative approaches to treating advanced cutaneous lymphoma allow for bridging therapies to successful transplant outcomes.
  • A psychosocial support program available to patients during clinic visits to screen for and support important issues that impact mental and emotional wellbeing.
  • Survivorship clinics that provide support and monitoring to patients throughout the course of the disease and post-transplant.

City of Hope is internationally recognized for its research and breakthrough treatments, has been named one of America’s top cancer hospitals by U.S. News & World Report for over a decade running and is a National Cancer Institute-designated comprehensive cancer center.

News & Breakthroughs


Help us turn innovative ideas into powerful new treatments
$ Other